Media Partners

Our

Pharma Intelligence is the leading provider of drug, device, company, clinical trial and market intelligence in the pharmaceutical and medtech markets. Our connected team of journalists, researchers and analysts are based in key markets around the globe. Drawing on a foundation of high-quality proprietary data you can trust that the insights gained through our solutions have the level of precision needed to make forward focused decisions with confidence.

Informa Pharma Intelligence Awards 2022
September, 1, 2022
The inaugural Informa Pharma Intelligence Awards recognize outstanding advancements and innovations in Japanese pharma and biotech, highlighting Japan’s integral role in the global healthcare market. The Awards will bring together leading innovators, to meet and network, discover new opportunities, and reflect on life-changing accomplishments made over the previous year.

Generics Bulletin from Informa Pharma Intelligence offers unrivalled coverage, news and analysis of the global generics, biosimilars and value-added medicines industries. This publication now delivers expanded Generics, Biosimilars and Value-Added Medicines content 24/7, with a new look, exciting new features and a customizable online platform to access the content on any internet or mobile device.

The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. Discussions include the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Biosimilars Review & Report (BR&R) provides education, commentary, and updates on the biosimilar marketplace. Visit https://biosimilarsrr.com/ for a frequently updated resource on the entire field, including biosimilar product profiles, an FDA approval and submissions database, and news on policy and coverage decisions. New articles are published regularly and may be accessed through visiting our website or via E-mail subscription.

Generics and Biosimilars Initiative (GaBI) fosters worldwide efficient use of high quality and safe medicines at an affordable price, thus advancing and supporting the idea of accessible, affordable and sustainable health care. GaBI aims to raise the scientific status of generic and biosimilar medicines, and to provide comprehensive high quality, scientifically sound, reliable, well-documented and up-to-date information about generic and biosimilar medicines. GaBI Online is an authoritative resource for global news on the recent developments in the field of generics and biosimilars, a repository of worldwide guidelines and an archive of related scientific information. Learn more or subscribe now.

Pharma Manufacturing is an Endeavor Business Media brand that serves the informational needs of pharma/biopharma professionals in manufacturing and operations, QA and QC, regulatory affairs, engineering and project management, packaging and corporate management. The brand provides in-depth coverage of the most pressing issues in the evolving pharma landscape and how industry thought leaders can tackle these challenges.

CONTACT US
IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION
C/O DYN SA - Rue de Cornavin 11 - 1201 Geneva, Switzerland
Telephone: +32 (0)477438729 (S. Kox)